RxDoctor Payments Data

Stephen Keane

Clinical Cardiac Electrophysiology · Philadelphia, PANPI 1043944481

Payments from drug & device makers

What this record shows

This record is dominated by grants: $95,951 of the $125,644 with a category attached, or 76.4%. 13 manufacturers reported payments, led by Abbott at 36.6% of the total. Reporting peaked in 2023 at $88,129 and has fallen 82.8% since, to $15,153 in 2025.

$125,644in general payments, 2019–2025

Across 285 payments — averaging $440.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$46K
  • Boston Scientific$39K
  • Medtronic$34K
  • Biotronik Inc.$4K
  • Philips North America LLC$1K
  • Biosense Webster, Inc.$313
  • plus $445 from 7 others

What the payments were for

  • Consulting fees$5,5224%
  • Speaking & faculty fees$7501%
  • Grants$95,95176%
  • Travel & lodging$9,7798%
  • Food & beverage$13,12610%
  • Education$5150%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$125,644 in reported general payments places this provider in the 85th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$41,751
Medicare patients
139
Services billed
295

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metoprolol Succinate12$254

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →